Peptide record

TPDB11989

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier standard
42 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11989
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier
Anti-infective peptides Cancer-related peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb AI4AVP BBPpredict
standard
No
A 42-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C203H311N55O60S1
CPTW
GV
4514.10
5.21
6
6
20
-3
0.78
0.205
97.38
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
1490
0.33
5
Residue Composition
number
4
A
1
R
1
N
3
D
0
C
3
E
1
Q
6
G
3
H
3
I
2
L
2
K
1
M
3
F
0
P
2
S
0
T
0
W
1
Y
6
V
Amino Acid Distribution
A: 4 R: 1 N: 1 D: 3 C: 0 E: 3 Q: 1 G: 6 H: 3 I: 3 L: 2 K: 2 M: 1 F: 3 P: 0 S: 2 T: 0 W: 0 Y: 1 V: 6
Chemical Descriptors
42 reviewed residue count
C203H311N55O60S1 sequence-only estimate (linear, free termini)
4514.10 sequence-only estimate (linear, free termini)
5.21 sequence-only estimate (linear, free termini)
-3 sequence-only estimate (linear, free termini)
0.78 sequence-only estimate (linear, free termini)
0.205 sequence-only estimate (linear, free termini)
Evidence Records 28 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.78 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml
Evidence 2 Activity

Activity

MIC
Antibacterial
1.56 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/
Evidence 3 Activity

Activity

MIC
Antibacterial
3.13 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 u
Evidence 4 Activity

Activity

MIC
Antibacterial
5.25 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5
Evidence 5 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

L. monocytogenes

Source & Reference

dbAMP

Other

epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml
Evidence 6 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP

Other

eumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml),
Evidence 7 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

Streptococcus agalactiae

Source & Reference

dbAMP

Other

aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml), S-mitis (MIC>50 ug/ml), abd S-sa
Evidence 8 Activity

Activity

MIC
Antifungal
0.78 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml
Evidence 9 Activity

Activity

MIC
Antifungal
1.56 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/
Evidence 10 Activity

Activity

MIC
Antifungal
3.13 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 u
Evidence 11 Activity

Activity

MIC
Antifungal
5.25 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5
Evidence 12 Activity

Activity

MIC
Antifungal
6.25 µg/mL

Target

L. monocytogenes

Source & Reference

dbAMP CAFPdb Antifungipept

Other

epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml
Evidence 13 Activity

Activity

MIC
Antifungal
6.25 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

eumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml),
Evidence 14 Activity

Activity

MIC
Antifungal
12.5 µg/mL

Target

Streptococcus agalactiae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml), S-mitis (MIC>50 ug/ml), abd S-sa
Evidence 15 Activity

Activity

MIC
Antiparasitic
0.78 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml
Evidence 16 Activity

Activity

MIC
Antiparasitic
1.56 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/
Evidence 17 Activity

Activity

MIC
Antiparasitic
3.13 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 u
Evidence 18 Activity

Activity

MIC
Antiparasitic
5.25 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5
Evidence 19 Activity

Activity

MIC
Antiparasitic
6.25 µg/mL

Target

L. monocytogenes

Source & Reference

NA

Other

epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml
Evidence 20 Activity

Activity

MIC
Antiparasitic
6.25 µg/mL

Target

Enterococcus faecalis

Source & Reference

NA

Other

eumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml),
Evidence 21 Activity

Activity

MIC
Antiparasitic
12.5 µg/mL

Target

Streptococcus agalactiae

Source & Reference

NA

Other

aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml), S-mitis (MIC>50 ug/ml), abd S-sa
Evidence 22 Activity

Activity

MIC
Antiviral
0.78 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml
Evidence 23 Activity

Activity

MIC
Antiviral
1.56 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/
Evidence 24 Activity

Activity

MIC
Antiviral
3.13 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

active against C. albicans (MIC 0.78 ug/ml), E. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 u
Evidence 25 Activity

Activity

MIC
Antiviral
5.25 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

. coli (MIC 1.56 ug/ml), S. epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5
Evidence 26 Activity

Activity

MIC
Antiviral
6.25 µg/mL

Target

L. monocytogenes

Source & Reference

NA

Other

epidermidis (MIC 3.13 ug/ml), S .pneumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml
Evidence 27 Activity

Activity

MIC
Antiviral
6.25 µg/mL

Target

Enterococcus faecalis

Source & Reference

NA

Other

eumoniae (MIC 6.25 ug/ml), S. aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml),
Evidence 28 Activity

Activity

MIC
Antiviral
12.5 µg/mL

Target

Streptococcus agalactiae

Source & Reference

NA

Other

aureus (MIC 5.25 ug/ml), L. monocytogenes (MIC 6.25 ug/ml), E. faecalis (MIC 6.25 ug/ml), S. agalactiae (MIC 12.5 ug/ml), P-aeruginosa (MIC>50 ug/ml), S-pyogenes (MIC>50 ug/ml), S-mitis (MIC>50 ug/ml), abd S-sa